New Jersey-based Enzon Pharmaceuticals Inc. has sold its Indianapolis plant that manufactures specialty drugs in a deal that
could top $300 million. The buyer says that the operations, which employ about 100, will remain in the city.
Greenwood-based Zimmerman Biotechnologies LLC hopes to become the first company in the United States to make generic insulin,
a long-awaited development in diabetes treatment. The Greenwood Common Council on Feb. 1 will consider an $8.4 million deal
that would finance construction of an insulin factory, as well as help Zimmerman with FDA-approval and equipment expenses.
St. Vincent Health is near an agreement to take over The Care Group LLC, the city’s largest independent physician practice
and largest cardiology group in the nation.
Massachusetts’ election of a Republican senator has put health reform legislation on life support. But for the health
care industry, reform is a reality that isn’t going to die.
The government has erected a high fence around a pot of $27 billion available to doctors and hospitals that successfully
computerize their patient records by next year, sparking complaints.
The Indianapolis-based drugmaker says a weaker dollar depressed earnings in the fourth quarter compared with a year ago.
A partnership between Indiana University School of Medicine and a medical school and hospital in Kenya has received an additional
$5 million grant from the U.S. Agency for International Development to expand health care services in the African nation.
Drug distribution firm that acquired former WellPoint subsidiary plans to consolidate specialty pharmacy work at local
airport facility.
Express Scripts Inc. on the west side of Indianapolis and Zipp Speed Weaponry in Speedway are scheduled Wednesday afternoon
to announce the
creation of hundreds of new jobs.
The Indianapolis-based health insurer earned $6.09 per share in 2009, excluding extraordinary items; it expects a $6-per-share
profit in 2010.
Two local researchers show why Eli Lilly and Co. and its peers are interested in developing medicines to treat automimmune
diseases: The costs of treating them are growing twice as fast as the prescription drug market.
Massachusetts’ election of a Republican senator has put health reform legislation on life support. But for the health
care industry, reform is a reality that isn’t going to die.
Shares of Lilly and partner Amylin rose on hopes that their new version of Byetta will be approved following U.S. regulators’
clearance of a similar drug.
Anti-tobacco advocates worry cost-cutting move could seriously diminish state’s efforts to curb Hoosier tobacco use.
St. Vincent Health’s agreement to lease the county hospital in Salem for five years is the latest in a string of deals
by Indianapolis hospital systems seeking a statewide presence.
Republicans in the Legislature have joined their counterparts in 25 other states in trying to prevent key aspects of reform
from taking effect in Indiana.
Greg Pemberton, a health care attorney at Ice Miller LLP, discussed the biggest changes he expects to come out of the federal
health reform bills. “It’s not going to be business as usual,” he said.
With the stunning victory of Republican Scott Brown in the Massachusetts election for U.S. Senate, Wall Street analysts
expect to see a "run" on health care stocks.
Joint resolutions in the state Legislature seek to amend the state constitution to block enforcement of provisions in the
federal bills that would require individuals to buy insurance and all but the smallest employers to help pay for it.
Associated X-Ray Services relocates headquarters from South Bend to Indianapolis and also announces the company has changed
its name to AXS Imaging.
